Please ensure Javascript is enabled for purposes of website accessibility

MORE Act Marijuana Legalization Bill Reintroduced in Congress

By Eric Volkman - May 28, 2021 at 4:27PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The bill is relaunched in the House of Representatives, but its prospects in the Senate look iffy at best.

A key marijuana legalization bill has returned to Congress. In the House of Representatives on Friday, Rep. Jerry Nadler, chairman of the Judiciary Committee, reintroduced the Marijuana Opportunity Reinvestment & Expungement Act (or MORE Act for short). If passed into law, this bill would remove cannabis from the Controlled Substances Act, decriminalizing it on the federal level.

Nadler, a Democrat, wrote in a statement: "Since I introduced the MORE Act last Congress, numerous states across the nation, including my home state of New York, have moved to legalize marijuana. Our federal laws must keep up with this pace."

Paper ballot under bowl of cannabis flowers.

Image source: Getty Images.

The MORE Act was passed in the House in December, but was not taken up for a vote in the Senate. Since that previous Congress was replaced, the bill must be formally reintroduced, hence Nadler's latest move.

While the House, still Democratic-controlled, is more than likely to pass the bill again, it probably doesn't have much of a chance in the Senate. For the most part, Republicans have been reluctant to vote in favor of any marijuana reform measures, and with a 50/50 split in the chamber, they can use the power of the filibuster to block any decriminalization bill.

Still, the return of the MORE Act is yet another reminder that marijuana legalization is a popular cause among the general U.S. population, and enjoys political support from Congressional Democrats, at least. 

In the wake of Nadler's move, shares of Canadian marijuana stocks generally went up; this could be due to hopes for a vast new market opening up for them, since they cannot directly sell cannabis in the country under the present legal regime. For example, Canopy Growth (CGC 4.76%), a bellwether north-of-our-border weedie, was up by 3.5% in late afternoon trading on Friday, outpacing the S&P 500's 0.3% rise.

 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
CGC
$3.30 (4.76%) $0.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.